Developer docs
API playgroundTry for free, no card

Search company profiles

Soiken

Full company profile

uuid003lv9d

Namestring
Soiken
Legal namestring
株式会社総医研ホールディングス
Websiteurl
soiken.com
Company typeenum
Public
Founded yearint
1994
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersToyonaka, Japan
HQ citystring
Toyonaka
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomarker evaluation services, clinical contract research, anti-fatigue supplements, functional food testing, healthcare support services
Industry2 codes
PRIMARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYAFALAAAO
Risk Assessment, Hazard Analysis & Food Defense/Fraud Programs
Agriculture & Food Production/Food Safety, Testing & Certification/Food Testing Laboratories (Microbiological, Chemical, Allergen)
NAICS code2 codes
  • Testing Laboratories and Services541380
  • Analytical Laboratory Instrument Manufacturing334516
SIC code3 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
  • Laboratory Analytical Instruments3826
Product category
Biomarker-based Healthcare & Contract Research
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Evaluation Testing Services (評価試験事業)
TypeProfessional Services
Description

Commissioned clinical evaluation testing services for foods and other products based on biomarker technology, serving food and pharmaceutical companies developing foods with functional claims (Tokuho, functional display foods).

soiken.com
2Biomarker Development (バイオマーカー開発事業)
TypeLicensing Royalties
Description

Technology licensing, co-development, and provision of biomarker technology to external companies and partners.

soiken.com
3Health Supplement Business (健康補助食品事業)
TypeTransaction Fee
Description

Sales of health supplements centered on the anti-fatigue product Imidapeptide (drinks and soft capsules), sold via direct e-commerce and wholesale to drugstores. The business will be strengthened as 'Self-medication Support Mail-order Business'.

soiken.com
4Cosmetics Business (化妆品事業)
TypeTransaction Fee
Description

Development and sales of high-functionality cosmetics using placental extracts. BB Laboratories brand sold domestically and internationally, with a planned wind-down of the subsidiary BB Laboratories by March 2026; domestic operations transfer to Japan Preventive Medicine.

soiken.com
5Healthcare Support Services (ヘルスケアサポート事業)
TypeProfessional Services
Description

Services provided to health insurance associations including health checkup promotion support, specific health guidance, diabetes prevention services, and various health management support services leveraging the company's medical institution network.

soiken.com
6Functional Ingredients Development (功能性素材開発事業)
TypeLicensing Royalties
Description

Development, sales, and technology licensing of functional ingredients centered on lactoferrin, conducted by NRL Pharma.

soiken.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1イミダペプチド
Description

疲劳项目中开发的抗疲劳成分(イミダゾールジペプチド),以饮料及软胶囊形式销售的主力健康保健食品。

soiken.com
Core offering1 text field

Soiken Holdings is a Japanese healthcare holding company that commercializes university-derived biomarker and biological evaluation technologies. It sells contracted clinical evaluation testing for foods and pharmaceuticals, develops and licenses biomarker technologies (ATMT for mental fatigue/dementia, HHV-6/HHV-7 fatigue quantification), produces the Imidapeptide-based anti-fatigue health supplement line, and delivers preventive healthcare support services to health insurance associations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Fatigue project identified 6 effective anti-fatigue components out of 23 candidates tested
+2 more records
Product overview1 text field

Soiken Holdings Inc. operates as a healthcare group centered on biomarker technology-based 'evidence' development across multiple business domains. The company functions as a pure holding company (持株会社) with four primary subsidiaries: Sōiken Institute (evaluation testing, biomarker development, healthcare support), Japan Preventive Medicine (health supplements, lactoferrin, cosmetics), NRL Pharma (functional ingredients), and Virus Medical Science Research Institute (fatigue quantification, gene therapy). The flagship product is Imidapeptide anti-fatigue supplements, supported by proprietary biomarker and biological evaluation systems including the ATMT diagnostic technology. The group provides B2B contract research services, B2C consumer health products, and healthcare support services to insurance associations.

Product and service7 records
1Imidapeptide (イミダペプチド) Anti-Fatigue Supplements
CategoryHealth supplements
Description

Beverages and soft capsules containing carnosine and anserine (imidazole dipeptides) developed from the company's fatigue project; sold to individual consumers seeking evidence-based anti-fatigue solutions.

2Evaluation Testing Services (評価試験事業)
CategoryContract research services
Description

Commissioned clinical evaluation testing for foods, pharmaceuticals and health products based on biomarker technology; supports Foods with Functional Claims (Tokuho) and other regulatory submissions for food and pharmaceutical clients.

3Biomarker Technology Licensing (バイオマーカー開発事業)
CategoryLicensing and R&D
Description

Technology licensing and co-development of proprietary biomarker platforms with external food and pharmaceutical companies; includes out-licensing of the ATMT method.

4Healthcare Support Services (ヘルスケアサポート事業)
CategoryPreventive healthcare services
Description

Preventive care services for health insurance associations including specific health examination promotion, specific health guidance, diabetes prevention programs, and health management support leveraging the company's medical institution network.

5Placental Extract Cosmetics (BB Laboratories)
CategoryCosmetics
Description

High-functionality cosmetics using placental extracts sold under the BB Laboratories brand domestically in Japan and internationally in China and other Asian markets.

6Functional Ingredients Development (NRL Pharma - Lactoferrin)
CategoryFunctional ingredients
Description

Development, sales and technology licensing of functional ingredients centered on lactoferrin, conducted by subsidiary NRL Pharma; ingredients are used in health supplements and cosmeceuticals.

7Imidapeptide Official Online Store (イミダペプチド公式通販)
CategoryE-commerce channel
Description

Direct-to-consumer e-commerce platform for Imidapeptide products, including subscription/regular purchase with Imeda Points loyalty rewards tied to shareholder benefit program.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierModerateTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership between Japan Preventive Medicine and Global Beauty Technology (a subsidiary of Gaolang Holdings Limited) for manufacturing and purchasing of health supplements for the China and Asian markets. Includes a basic manufacturing and purchasing contract for joint product development and distribution expansion in Asian markets.

2Hangzhou Golong Holding Co., Ltd.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-02-01
Description

Capital and business partnership formed in February 2019 for cosmetics sales and health supplement distribution in the Chinese market. Golong Holding is the largest shareholder at 17.68% ownership (as of June 2025). The partnership aims to build distribution networks and joint product development for the Chinese and broader Asian markets.

soiken.com
Strategic tierModerateTypeStrategic or Co-development PartnerAnnounced on2015-05-01
Description

Business and capital partnership established in May 2015 for building cooperative relationships for cosmetics sales in the Chinese market. Formed as part of the company's international expansion strategy for cosmetics.

4Professor Kondo Katsuya (東京慈恵会医科大学 近藤一博教授)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint venture established with Professor Kondo of The Jikei University School of Medicine, co-founding Virus Medical Science Research Institute (株式会社ウイルス医科学研究所). The company conducts R&D on fatigue quantification technology and gene therapy vectors using the professor's human herpes virus research成果.

soiken.com
Strategic tierModerateTypeTechnology or Integration
Description

Licensing partner for ATMT technology. Elc Corporation commercialized the ATMT as a 'Brain Age Meter ATMT' product, providing reach to consumer health device market.

6一般社団法人専門医ヘルスケアネットワーク (Medical Specialist Healthcare Network)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

A general incorporated association partner for healthcare network development, linked in the footer as a partner organization.

soiken.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Japanese functional food and beverage company with probiotic and health-positioned consumer products. Comparable in functional food positioning and DTC retail distribution in Japan to Soiken's Imidapeptide brand.

2Fancl Corporation
TypeBroad incumbent
Description

Japanese health and cosmetics company focused on supplements and skincare, with direct-to-consumer e-commerce and drugstore distribution. Comparable channel strategy and supplement customer base to Soiken's Imidapeptide business.

TypeBroad incumbent
Description

Japanese dairy and functional ingredients company with lactoferrin-related products and functional food lines. Direct adjacency to Soiken's lactoferrin development at NRL Pharma, overlapping in functional ingredient IP and Japanese health food channels.

4EPS Holdings
TypeDirect peer
Description

Japanese CRO and healthcare solutions provider offering clinical trial support, site management, and SMO services. Comparable to Soiken's clinical evaluation testing and healthcare support offerings to enterprise customers.

5Kobayashi Pharmaceutical
TypeBroad incumbent
Description

Major Japanese OTC pharmaceutical and household products company with strong drugstore channel presence. Competes with Soiken in Japanese drugstore retail distribution of health supplements and self-medication products.

TypeDirect peer
Description

Japanese Contract Research Organization (CRO) providing clinical development, clinical trial services, and healthcare support. Most directly comparable to Soiken Institute's evaluation testing services and B2B healthcare support business, serving overlapping food/pharmaceutical enterprise customers.

7H.U. Group Holdings (formerly SRL/Hitachi)
TypeBroad incumbent
Description

Japanese clinical laboratory and healthcare services conglomerate. Comparable in clinical testing, biomarker services, and healthcare support offerings to Soiken Institute's evaluation testing and healthcare support divisions.

TypeBroad incumbent
Description

Diversified Japanese healthcare company with significant pharmaceutical, nutraceutical, and consumer health product portfolios. Comparable to Soiken in the Japanese consumer health and functional food segments, though at vastly larger scale.

9Taisho Pharmaceutical Holdings
TypeBroad incumbent
Description

Large Japanese OTC and supplement company with significant self-medication and consumer health products business. Broad incumbent in the same Japanese supplement and self-medication space as Soiken's Imidapeptide brand, with far larger distribution and marketing scale.

TypeRegional player
Description

Japanese clinical testing laboratory offering biomarker and diagnostic testing services to medical institutions. Comparable to Soiken Institute's clinical evaluation testing business with overlapping biomarker/diagnostic testing methodologies and food/pharma enterprise customers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Soiken

Biomarker-based Healthcare & Contract Researchsoiken.com

Soiken firmographics

Firmographics
Name
Soiken
Legal name
株式会社総医研ホールディングス
Website
https://soiken.com
Company type
Public
Founded year
1994
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Soiken industry classification

Industry
Product category
Biomarker-based Healthcare & Contract Research
NAICS
Testing Laboratories and Services (541380), Analytical Laboratory Instrument Manufacturing (334516)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYAFALAAAO
Risk Assessment, Hazard Analysis & Food Defense/Fraud Programs
Agriculture & Food Production/Food Safety, Testing & Certification/Food Testing Laboratories (Microbiological, Chemical, Allergen)

Keywords

  • Biomarker evaluation services
  • Clinical contract research
  • Anti-fatigue supplements
  • Functional food testing
  • Healthcare support services

Where Soiken is headquartered

Location

Headquarters

HQ city
Toyonaka
HQ country
Japan
HQ region
Asia

Offices2 records

Markets served

Soiken business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. Evaluation Testing Services (評価試験事業): Commissioned clinical evaluation testing services for foods and other products based on biomarker technology, serving food and pharmaceutical companies developing foods with functional claims (Tokuho, functional display foods).
  2. Biomarker Development (バイオマーカー開発事業): Technology licensing, co-development, and provision of biomarker technology to external companies and partners.
  3. Health Supplement Business (健康補助食品事業): Sales of health supplements centered on the anti-fatigue product Imidapeptide (drinks and soft capsules), sold via direct e-commerce and wholesale to drugstores. The business will be strengthened as 'Self-medication Support Mail-order Business'.
  4. Cosmetics Business (化妆品事業): Development and sales of high-functionality cosmetics using placental extracts. BB Laboratories brand sold domestically and internationally, with a planned wind-down of the subsidiary BB Laboratories by March 2026; domestic operations transfer to Japan Preventive Medicine.
  5. Healthcare Support Services (ヘルスケアサポート事業): Services provided to health insurance associations including health checkup promotion support, specific health guidance, diabetes prevention services, and various health management support services leveraging the company's medical institution network.
  6. Functional Ingredients Development (功能性素材開発事業): Development, sales, and technology licensing of functional ingredients centered on lactoferrin, conducted by NRL Pharma.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Soiken product offering

Product offering

Core offering

Soiken Holdings is a Japanese healthcare holding company that commercializes university-derived biomarker and biological evaluation technologies. It sells contracted clinical evaluation testing for foods and pharmaceuticals, develops and licenses biomarker technologies (ATMT for mental fatigue/dementia, HHV-6/HHV-7 fatigue quantification), produces the Imidapeptide-based anti-fatigue health supplement line, and delivers preventive healthcare support services to health insurance associations.

Product overview

Soiken Holdings Inc. operates as a healthcare group centered on biomarker technology-based 'evidence' development across multiple business domains. The company functions as a pure holding company (持株会社) with four primary subsidiaries: Sōiken Institute (evaluation testing, biomarker development, healthcare support), Japan Preventive Medicine (health supplements, lactoferrin, cosmetics), NRL Pharma (functional ingredients), and Virus Medical Science Research Institute (fatigue quantification, gene therapy). The flagship product is Imidapeptide anti-fatigue supplements, supported by proprietary biomarker and biological evaluation systems including the ATMT diagnostic technology. The group provides B2B contract research services, B2C consumer health products, and healthcare support services to insurance associations.

Differentiator

Problem solved

Functional benefit

Brands

  • イミダペプチド: 疲劳项目中开发的抗疲劳成分(イミダゾールジペプチド),以饮料及软胶囊形式销售的主力健康保健食品。

Products and services

  • Imidapeptide (イミダペプチド) Anti-Fatigue Supplements Beverages and soft capsules containing carnosine and anserine (imidazole dipeptides) developed from the company's fatigue project; sold to individual consumers seeking evidence-based anti-fatigue solutions.
  • Evaluation Testing Services (評価試験事業) Commissioned clinical evaluation testing for foods, pharmaceuticals and health products based on biomarker technology; supports Foods with Functional Claims (Tokuho) and other regulatory submissions for food and pharmaceutical clients.
  • Biomarker Technology Licensing (バイオマーカー開発事業) Technology licensing and co-development of proprietary biomarker platforms with external food and pharmaceutical companies; includes out-licensing of the ATMT method.
  • Healthcare Support Services (ヘルスケアサポート事業) Preventive care services for health insurance associations including specific health examination promotion, specific health guidance, diabetes prevention programs, and health management support leveraging the company's medical institution network.
  • Placental Extract Cosmetics (BB Laboratories) High-functionality cosmetics using placental extracts sold under the BB Laboratories brand domestically in Japan and internationally in China and other Asian markets.
  • Functional Ingredients Development (NRL Pharma - Lactoferrin) Development, sales and technology licensing of functional ingredients centered on lactoferrin, conducted by subsidiary NRL Pharma; ingredients are used in health supplements and cosmeceuticals.
  • Imidapeptide Official Online Store (イミダペプチド公式通販) Direct-to-consumer e-commerce platform for Imidapeptide products, including subscription/regular purchase with Imeda Points loyalty rewards tied to shareholder benefit program.

Quantifiable outcome

  • Fatigue project identified 6 effective anti-fatigue components out of 23 candidates tested
  • +2 more outcomes

Companies that use Soiken

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Soiken technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Soiken partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered moderate, core and minor.

  • Global Beauty Technology株式会社 (高浪控股股份有限公司 group)moderateStrategic or Co-development Partner · 1 January 2024Partnership between Japan Preventive Medicine and Global Beauty Technology (a subsidiary of Gaolang Holdings Limited) for manufacturing and purchasing of health supplements for the China and Asian markets. Includes a basic manufacturing and purchasing contract for joint product development and distribution expansion in Asian markets.
  • Hangzhou Golong Holding Co., Ltd.coreStrategic or Co-development Partner · 1 February 2019Capital and business partnership formed in February 2019 for cosmetics sales and health supplement distribution in the Chinese market. Golong Holding is the largest shareholder at 17.68% ownership (as of June 2025). The partnership aims to build distribution networks and joint product development for the Chinese and broader Asian markets.
  • Beautyplus Holdings Hongkong LimitedmoderateStrategic or Co-development Partner · 1 May 2015Business and capital partnership established in May 2015 for building cooperative relationships for cosmetics sales in the Chinese market. Formed as part of the company's international expansion strategy for cosmetics.
  • Professor Kondo Katsuya (東京慈恵会医科大学 近藤一博教授)coreStrategic or Co-development PartnerJoint venture established with Professor Kondo of The Jikei University School of Medicine, co-founding Virus Medical Science Research Institute (株式会社ウイルス医科学研究所). The company conducts R&D on fatigue quantification technology and gene therapy vectors using the professor's human herpes virus research成果.
  • Elc Corporation (株式会社エルクコーポレーション)moderateTechnology or IntegrationLicensing partner for ATMT technology. Elc Corporation commercialized the ATMT as a 'Brain Age Meter ATMT' product, providing reach to consumer health device market.
  • 一般社団法人専門医ヘルスケアネットワーク (Medical Specialist Healthcare Network)minorStrategic or Co-development PartnerA general incorporated association partner for healthcare network development, linked in the footer as a partner organization.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Soiken competitors and assessment

Company assessment

Broad incumbents

  • Yakult Honsha: Japanese functional food and beverage company with probiotic and health-positioned consumer products. Comparable in functional food positioning and DTC retail distribution in Japan to Soiken's Imidapeptide brand.
  • Fancl Corporation: Japanese health and cosmetics company focused on supplements and skincare, with direct-to-consumer e-commerce and drugstore distribution. Comparable channel strategy and supplement customer base to Soiken's Imidapeptide business.
  • Morinaga Milk Industry: Japanese dairy and functional ingredients company with lactoferrin-related products and functional food lines. Direct adjacency to Soiken's lactoferrin development at NRL Pharma, overlapping in functional ingredient IP and Japanese health food channels.
  • Kobayashi Pharmaceutical: Major Japanese OTC pharmaceutical and household products company with strong drugstore channel presence. Competes with Soiken in Japanese drugstore retail distribution of health supplements and self-medication products.
  • H.U. Group Holdings (formerly SRL/Hitachi): Japanese clinical laboratory and healthcare services conglomerate. Comparable in clinical testing, biomarker services, and healthcare support offerings to Soiken Institute's evaluation testing and healthcare support divisions.
  • Otsuka Holdings: Diversified Japanese healthcare company with significant pharmaceutical, nutraceutical, and consumer health product portfolios. Comparable to Soiken in the Japanese consumer health and functional food segments, though at vastly larger scale.
  • Taisho Pharmaceutical Holdings: Large Japanese OTC and supplement company with significant self-medication and consumer health products business. Broad incumbent in the same Japanese supplement and self-medication space as Soiken's Imidapeptide brand, with far larger distribution and marketing scale.

Direct peers

  • EPS Holdings: Japanese CRO and healthcare solutions provider offering clinical trial support, site management, and SMO services. Comparable to Soiken's clinical evaluation testing and healthcare support offerings to enterprise customers.
  • CMIC Holdings: Japanese Contract Research Organization (CRO) providing clinical development, clinical trial services, and healthcare support. Most directly comparable to Soiken Institute's evaluation testing services and B2B healthcare support business, serving overlapping food/pharmaceutical enterprise customers.

Regional players

  • SRL (subsidiary of H.U. Group Holdings): Japanese clinical testing laboratory offering biomarker and diagnostic testing services to medical institutions. Comparable to Soiken Institute's clinical evaluation testing business with overlapping biomarker/diagnostic testing methodologies and food/pharma enterprise customers.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Soiken social profiles

Digital presence

Soiken financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Soiken leadership team

Management profile

Number of profiles

Profiles9 records

Soiken subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Soiken funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Soiken M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Soiken

What does Soiken do?

Soiken Holdings is a Japanese healthcare holding company that commercializes university-derived biomarker and biological evaluation technologies. It sells contracted clinical evaluation testing for foods and pharmaceuticals, develops and licenses biomarker technologies (ATMT for mental fatigue/dementia, HHV-6/HHV-7 fatigue quantification), produces the Imidapeptide-based anti-fatigue health supplement line, and delivers preventive healthcare support services to health insurance associations.

Is Soiken a public or private company?

Soiken is a public company. It is classified as public and is currently operating.

When was Soiken founded?

Soiken was founded in 1994. It employs 51 to 100 people.

Where is Soiken based?

Soiken is headquartered in Toyonaka, Japan, in the Asia region.

How does Soiken make money?

Six revenue lines are on record. Evaluation Testing Services (評価試験事業) is the primary driver. The others are biomarker Development (バイオマーカー開発事業), health Supplement Business (健康補助食品事業), cosmetics Business (化妆品事業), healthcare Support Services (ヘルスケアサポート事業) and functional Ingredients Development (功能性素材開発事業).

Who are Soiken's main competitors?

Broad incumbents on record are Yakult Honsha, Fancl Corporation, Morinaga Milk Industry, Kobayashi Pharmaceutical, H.U. Group Holdings (formerly SRL/Hitachi), Otsuka Holdings and Taisho Pharmaceutical Holdings. Direct peers are EPS Holdings and CMIC Holdings. SRL (subsidiary of H.U. Group Holdings) is listed as a regional player.

Does Soiken have an API?

No public API is recorded for Soiken.

What industry is Soiken in?

Soiken's product category is Biomarker-based Healthcare & Contract Research. Its primary akta.pro industry code is HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints, with a secondary code of AFALAAAO, Risk Assessment, Hazard Analysis & Food Defense/Fraud Programs. Its NAICS code is 541380 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales